Having trouble accessing articles? Reset your cache.

Cardio panel posits Pradaxa approval

An FDA panel voted 9-0 that Pradaxa dabigatran from Boehringer Ingelheim GmbH (Ingelheim, Germany) should be approved for the reduction of stroke

Read the full 220 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE